
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Broad strategies for neutralizing SARS-CoV-2 and other human coronaviruses with monoclonal antibodies
Zhiyang Ling, Chunyan Yi, Xiaoyu Sun, et al.
Science China Life Sciences (2022) Vol. 66, Iss. 4, pp. 658-678
Open Access | Times Cited: 9
Zhiyang Ling, Chunyan Yi, Xiaoyu Sun, et al.
Science China Life Sciences (2022) Vol. 66, Iss. 4, pp. 658-678
Open Access | Times Cited: 9
Showing 9 citing articles:
Recent advances in chemical protein synthesis: method developments and biological applications
Suwei Dong, Ji‐Shen Zheng, Yiming Li, et al.
Science China Chemistry (2024) Vol. 67, Iss. 4, pp. 1060-1096
Closed Access | Times Cited: 56
Suwei Dong, Ji‐Shen Zheng, Yiming Li, et al.
Science China Chemistry (2024) Vol. 67, Iss. 4, pp. 1060-1096
Closed Access | Times Cited: 56
Enhanced potency of an IgM-like nanobody targeting conserved epitope in SARS-CoV-2 spike N-terminal domain
Bo Liu, Honghui Liu, Pu Han, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Bo Liu, Honghui Liu, Pu Han, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Broadly neutralizing antibodies to combat influenza virus infection
Xiaoyu Sun, Hanwen Ma, Xuanjia Wang, et al.
Antiviral Research (2023) Vol. 221, pp. 105785-105785
Closed Access | Times Cited: 9
Xiaoyu Sun, Hanwen Ma, Xuanjia Wang, et al.
Antiviral Research (2023) Vol. 221, pp. 105785-105785
Closed Access | Times Cited: 9
Progress in immunotherapy
Bing Sun, Ningshao Xia, Xuan Zhang
Science China Life Sciences (2023) Vol. 66, Iss. 4, pp. 653-657
Open Access | Times Cited: 7
Bing Sun, Ningshao Xia, Xuan Zhang
Science China Life Sciences (2023) Vol. 66, Iss. 4, pp. 653-657
Open Access | Times Cited: 7
Treatment for Covid-19 with SARS-CoV-2 neutralizing antibody BRII-196(Ambavirumab) plus BRII-198(Lomisivir): a retrospective cohort study
Qin Yalan, Hao Lingfang, Liu Xisong, et al.
BMC Pharmacology and Toxicology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Qin Yalan, Hao Lingfang, Liu Xisong, et al.
BMC Pharmacology and Toxicology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
A human antibody potently neutralizes RSV by targeting the conserved hydrophobic region of prefusion F
Chunyan Yi, Caixia Su, Xiaoyu Sun, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 4, pp. 729-742
Open Access | Times Cited: 2
Chunyan Yi, Caixia Su, Xiaoyu Sun, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 4, pp. 729-742
Open Access | Times Cited: 2
Longitudinal profiling of B cells primed by mRNA vaccine and recalled by Omicron variants uncovers antibodies broadly neutralizing sarbecoviruses
Xixian Chen, Ling Li, Ruiping Du, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Xixian Chen, Ling Li, Ruiping Du, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Engineered bispecific antibodies with enhanced breadth and potency against SARS-CoV-2 variants and SARS-related coronaviruses
Fangfang Chang, Qian Wu, Yabin Hu, et al.
Medical Microbiology and Immunology (2024) Vol. 213, Iss. 1
Closed Access
Fangfang Chang, Qian Wu, Yabin Hu, et al.
Medical Microbiology and Immunology (2024) Vol. 213, Iss. 1
Closed Access
Children exhibit a robust B-cell response to Omicron BA.2 after breakthrough infection with limited influence from the original antigenic sin
Zhiyang Ling, Zhangqian Zheng, Lingli Xu, et al.
Cellular and Molecular Immunology (2024)
Closed Access
Zhiyang Ling, Zhangqian Zheng, Lingli Xu, et al.
Cellular and Molecular Immunology (2024)
Closed Access